secwatch.observer — SEC 8-K summary
======================================

Issuer:     VOLITIONRX LTD (VNRX)
CIK:        0000093314
Form:       8-K
Filed at:   2024-12-09T23:59:59+00:00
Accession:  0001477932-24-007944
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VolitionRx raises up to $1.9M in registered direct offering with warrants for additional $2.7M
--------------------------------------------------------------------------------

- Offering includes 445,648 Insider Shares at $0.5722 and 2,857,389 shares with warrants at $0.5722.
- Form A warrants exercisable at $0.5722/share, Form B at $0.71525/share, both expire Dec 2029.
- Gross proceeds upfront ~$1.9M; potential additional $2.7M if warrants fully exercised.
- Proceeds for R&D, clinical studies, product commercialization, and working capital.
- Insiders participate; no placement agent; closing expected on Dec 9, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/93314/000147793224007944/0001477932-24-007944-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/93314/000147793224007944/vnrx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-24-007944

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer